Dépistages : que faire au-delà de 75 ans ? [To screen or not to screen after age 75 ?]

Details

Ressource 1Request a copy Sous embargo indéterminé.
State: Public
Version: Final published version
License: Not specified
Serval ID
serval:BIB_D9E04065FC98
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Dépistages : que faire au-delà de 75 ans ? [To screen or not to screen after age 75 ?]
Journal
Revue medicale suisse
Author(s)
Vilas Boas A., Selby K., Cornuz J., Büla C., Nguyen S.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
11/11/2020
Peer-reviewed
Oui
Volume
16
Number
714
Pages
2156-2159
Language
french
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Abstract
The older population is heterogenous: at the same age, elderly patients can be robust, frail or dependent. Screening decisions must be individualized, taking into account the remaining life expectancy, the Time to Benefit (TTB: delay until preventive care gives a benefit), and patient preferences. Thus, robust patients, who have a longer life expectancy, can still benefit from some screening tests over age 75 that are inappropriate in vulnerable or dependent patients whose life expectancy is shorter than the TTB. Discussing life expectancy issues remains difficult outside of crises but medical encounters are unique opportunities to inquire about individual preferences and expectations, in order to define care objectives and discuss advanced care planning.
Pubmed
Create date
16/11/2020 13:39
Last modification date
25/11/2020 6:26
Usage data